Affiliate-supportedIndependent editorialWe never sell medicationSee how
3-way comparison
Side-by-side breakdown — efficacy, cost, regulatory status, and who each option fits best.
| Attribute | Ozempic | Wegovy | Compounded Semaglutide |
|---|---|---|---|
| Generic name | semaglutide | semaglutide | semaglutide (compounded) |
| Drug class | — | — | — |
| Regulatory status | FDA approved | FDA approved | Compounded |
| Manufacturer | Novo Nordisk | Novo Nordisk | Various compounding pharmacies |
| Avg retail price | $968/mo | $1349/mo | $250/mo |
| Without insurance | $968–$1100/mo | $1349–$1500/mo | $99–$350/mo |
| Savings card max | $25/mo | $0/mo | $0/mo |
| Shortage status |
| resolved |
| resolved |
| not_listed |
Ozempic (semaglutide), Wegovy (semaglutide), and Compounded Semaglutide (semaglutide (compounded)) are GLP-1 medications used for weight management or type 2 diabetes. Key differences: Ozempic is FDA-approved, Wegovy is FDA-approved, Compounded Semaglutide is compounded.
Effectiveness varies by individual. In clinical trials, tirzepatide-based drugs (Mounjaro, Zepbound) produced ~22% average body-weight loss vs ~15% for semaglutide-based (Ozempic, Wegovy). Discuss with your prescriber.
Cash retail price: Compounded Semaglutide $250/mo · Ozempic $968/mo · Wegovy $1349/mo. Compounded versions through telehealth typically run 60-80% less.
See per-drug deep dives: Ozempic review · Wegovy review · Compounded Semaglutide review
Drill down into any pair from the three above for deeper side-by-side analysis.
Dose conversion + transition timeline for each directional switch.